Analysts expect GRAIL to announce earnings of ($2.66) per share and revenue of $42.39 million for the quarter. On average, analysts expect GRAIL to post $-11 EPS for the current fiscal year and $-11 EPS for the next fiscal year. Get GRAIL alerts:GRAIL Stock PerformanceNASDAQ GRAL traded up $1.04 during trading hours on Tuesday, hitting $71.31. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $67.78. GRAIL Company Profile(Get Free Report)GRAIL, Inc (NASDAQ: GRAL) is a biotechnology company dedicated to the early detection of cancer through a multi-cancer blood test.